The compliance risk that many Italian life sciences companies are still underestimating before Sanità Trasparente becomes operational
Author

International Expert in Ethics, Compliance, and Transparency
Thought Leader in Reporting on the Italian Sunshine Act
Edoardo, a former MedTech compliance manager, has over 25 years of experience in compliance and transparency. A recognized opinion leader, Edoardo has led ethics programs at major pharmaceutical companies and offers strategic insights into compliance practices in Italy.
Recent Blogs
Cerchi supporto per la compliance al Sunshine Act?
Hai domande pratiche?
Dai un’occhiata alla nostra sezione Domande Frequenti per risposte chiare su scadenze, obblighi e strategie.
A recurring pattern is emerging among pharmaceutical, medical device, food supplement, and veterinary companies in Italy that should concern any manager responsible for overseeing Italian Sunshine Reporting (i.e., disclosures to Sanità Trasparente).
Many companies have studied the regulation, participated in internal and external training, and broadly understood what the Italian transparency framework requires, yet they are still approaching periodic data submission moments to the Ministry not fully prepared.
Not because they have ignored the regulation, but because they have misunderstood where the most complex work actually begins.
The regulation is not the most difficult part.
Implementation and organizational readiness are.
Sanità Trasparente Reporting: operational challenges in transparency compliance for the human and animal life sciences sector in Italy
Sanità Trasparente is set to become one of the most significant transparency obligations for life sciences companies in Italy (both human and animal health), requiring accurate disclosures to healthcare professionals and healthcare organizations, strong governance of master data, and the generation of submissions to the Ministry’s registry in an unusual format—XML.
The Italian transparency law requires life sciences companies to publicly disclose transfers of value to healthcare professionals and healthcare organizations, including fees, meals, travel, agreements, event sponsorships, and other forms of collaboration (monetary, goods, and services).
Today, the regulatory framework is relatively well understood. What remains far less clear within the life sciences community is what is practically required to meet these obligations in a way that is accurate, defensible, and ready for potential audits.
The risk does not begin when the XML file is uploaded to the Ministry’s platform. It begins months earlier. It begins when data ownership has not been clearly defined, when the CRM system does not capture the required fields, when Finance and Marketing work on different versions of the same data, and when healthcare professional master data has not been verified against authoritative sources.
By the time companies reach the point of generating XML files for submission to the registry, they typically find themselves in one of two situations: either they have a solid and structured operational foundation, or they are trying to reconstruct information that was never properly captured in the first place.
For this reason, teams that treat Italian Sunshine Reporting as a simple “reporting obligation” systematically encounter more difficulties than those that manage it as a cross-functional operational discipline.
Three areas that often catch companies unprepared
Initial master data quality is a prerequisite for transparency compliance.
The accuracy of disclosures depends directly on the quality of data related to healthcare professionals (HCPs) and healthcare organizations (HCOs) that have interacted with the company. Incomplete, duplicated, or unverified records do not only create reporting difficulties but also undermine the company’s ability to defend its data in case of disputes. If the organization does not have clear ownership of HCP/HCO master data and a structured process to maintain it, the entire system rests on fragile foundations.
Gaps in cross-functional responsibility are the primary source of errors.
Sunshine Reporting simultaneously involves Legal, Compliance, Finance, IT, Marketing, Clinical, and Commercial Operations. In practice, this often leads to responsibility being dispersed across these functions. Who decides whether a complex activity must be disclosed? In joint initiatives with other companies, which entity is responsible for reporting to the Ministry? Who reconciles data between event management systems and financial ERP systems? Who is responsible for taking action when discrepancies arise? Who manages intermediary transfers of value? Without clear answers, last-minute reconciliations become the norm—and it is precisely in these final stages that errors tend to multiply.
Technical submission is more complex than many teams expect.
The Sanità Trasparente registry requires both structural and semantic validation for XML file uploads and includes control mechanisms within the submission platform. A file may be technically valid from a structural standpoint and still fail submission checks if required fields or logical relationships do not meet registry requirements. It is essential to understand the difference between “the file has passed technical validation” and “the disclosure is actually correct.” Many teams only discover this distinction during their first real submission cycle, when there is no longer time to fix the process in an orderly way.
Timelines are more urgent than they appear
It may be tempting to treat compliance preparation as something to address later, when the submission window approaches. In practice, this approach rarely works.
The activities that truly determine the quality of submission include aligning cross-functional processes and procedures (and across affiliates in multinational groups), cleaning and governing master data, configuring systems to capture the correct information at the moment activities occur, and building proper audit trails.
All of these require time. They cannot be implemented retroactively in the final weeks.
For organizations that have not yet clearly defined their operating model, the window to do so in a structured way—without pressure—is now.
Where to get up to speed quickly
For organizations looking to close this gap efficiently, there are practical options worth considering.
The “Italian Sunshine Reporting” community (see Italiansunshinereporting.it) regularly publishes updates, commentary, and Q&A to build a useful knowledge base. More importantly, it organizes Italian Sunshine Reporting Executive Operational Readiness Sessions, bringing together compliance, legal, finance, IT, marketing, clinical operations, R&D and commercial professionals for a dedicated working day focused on translating regulatory requirements into a truly sustainable operational model.
These sessions are led by professionals who work in this space daily, including experts from Delfino e Associati Willkie Farr & Gallagher, Merqurio, Vector Health Compliance, as well as former transparency operations leaders from Pfizer and Otsuka, and leading Italian experts in Sunshine Act reporting.
What distinguishes these initiatives from traditional conferences is their practical, operational, and interactive format. Participants do not just listen—they work directly on materials and leave with a clear understanding of how to generate their own XML submission files and how to avoid common implementation errors through shared real-world experience.
Previous editions held in 2026 were fully booked, with an average participant rating of 9.5 out of 10.
If you are responsible for the accuracy and defensibility of Italian Sunshine Reporting in your organization, this represents one of the most direct ways to bring your team to a real level of readiness before operational pressure increases.
A recurring pattern is emerging among pharmaceutical, medical device, food supplement, and veterinary companies in Italy that should concern any manager responsible for overseeing Italian Sunshine Reporting (i.e., disclosures to Sanità Trasparente).
Many companies have studied the regulation, participated in internal and external training, and broadly understood what the Italian transparency framework requires, yet they are still approaching periodic data submission moments to the Ministry not fully prepared.
Not because they have ignored the regulation, but because they have misunderstood where the most complex work actually begins.
The regulation is not the most difficult part.
Implementation and organizational readiness are.
Sanità Trasparente Reporting: operational challenges in transparency compliance for the human and animal life sciences sector in Italy
Sanità Trasparente is set to become one of the most significant transparency obligations for life sciences companies in Italy (both human and animal health), requiring accurate disclosures to healthcare professionals and healthcare organizations, strong governance of master data, and the generation of submissions to the Ministry’s registry in an unusual format—XML.
The Italian transparency law requires life sciences companies to publicly disclose transfers of value to healthcare professionals and healthcare organizations, including fees, meals, travel, agreements, event sponsorships, and other forms of collaboration (monetary, goods, and services).
Today, the regulatory framework is relatively well understood. What remains far less clear within the life sciences community is what is practically required to meet these obligations in a way that is accurate, defensible, and ready for potential audits.
The risk does not begin when the XML file is uploaded to the Ministry’s platform. It begins months earlier. It begins when data ownership has not been clearly defined, when the CRM system does not capture the required fields, when Finance and Marketing work on different versions of the same data, and when healthcare professional master data has not been verified against authoritative sources.
By the time companies reach the point of generating XML files for submission to the registry, they typically find themselves in one of two situations: either they have a solid and structured operational foundation, or they are trying to reconstruct information that was never properly captured in the first place.
For this reason, teams that treat Italian Sunshine Reporting as a simple “reporting obligation” systematically encounter more difficulties than those that manage it as a cross-functional operational discipline.
Three areas that often catch companies unprepared
Initial master data quality is a prerequisite for transparency compliance.
The accuracy of disclosures depends directly on the quality of data related to healthcare professionals (HCPs) and healthcare organizations (HCOs) that have interacted with the company. Incomplete, duplicated, or unverified records do not only create reporting difficulties but also undermine the company’s ability to defend its data in case of disputes. If the organization does not have clear ownership of HCP/HCO master data and a structured process to maintain it, the entire system rests on fragile foundations.
Gaps in cross-functional responsibility are the primary source of errors.
Sunshine Reporting simultaneously involves Legal, Compliance, Finance, IT, Marketing, Clinical, and Commercial Operations. In practice, this often leads to responsibility being dispersed across these functions. Who decides whether a complex activity must be disclosed? In joint initiatives with other companies, which entity is responsible for reporting to the Ministry? Who reconciles data between event management systems and financial ERP systems? Who is responsible for taking action when discrepancies arise? Who manages intermediary transfers of value? Without clear answers, last-minute reconciliations become the norm—and it is precisely in these final stages that errors tend to multiply.
Technical submission is more complex than many teams expect.
The Sanità Trasparente registry requires both structural and semantic validation for XML file uploads and includes control mechanisms within the submission platform. A file may be technically valid from a structural standpoint and still fail submission checks if required fields or logical relationships do not meet registry requirements. It is essential to understand the difference between “the file has passed technical validation” and “the disclosure is actually correct.” Many teams only discover this distinction during their first real submission cycle, when there is no longer time to fix the process in an orderly way.
Timelines are more urgent than they appear
It may be tempting to treat compliance preparation as something to address later, when the submission window approaches. In practice, this approach rarely works.
The activities that truly determine the quality of submission include aligning cross-functional processes and procedures (and across affiliates in multinational groups), cleaning and governing master data, configuring systems to capture the correct information at the moment activities occur, and building proper audit trails.
All of these require time. They cannot be implemented retroactively in the final weeks.
For organizations that have not yet clearly defined their operating model, the window to do so in a structured way—without pressure—is now.
Where to get up to speed quickly
For organizations looking to close this gap efficiently, there are practical options worth considering.
The “Italian Sunshine Reporting” community (see Italiansunshinereporting.it) regularly publishes updates, commentary, and Q&A to build a useful knowledge base. More importantly, it organizes Italian Sunshine Reporting Executive Operational Readiness Sessions, bringing together compliance, legal, finance, IT, marketing, clinical operations, R&D and commercial professionals for a dedicated working day focused on translating regulatory requirements into a truly sustainable operational model.
These sessions are led by professionals who work in this space daily, including experts from Delfino e Associati Willkie Farr & Gallagher, Merqurio, Vector Health Compliance, as well as former transparency operations leaders from Pfizer and Otsuka, and leading Italian experts in Sunshine Act reporting.
What distinguishes these initiatives from traditional conferences is their practical, operational, and interactive format. Participants do not just listen—they work directly on materials and leave with a clear understanding of how to generate their own XML submission files and how to avoid common implementation errors through shared real-world experience.
Previous editions held in 2026 were fully booked, with an average participant rating of 9.5 out of 10.
If you are responsible for the accuracy and defensibility of Italian Sunshine Reporting in your organization, this represents one of the most direct ways to bring your team to a real level of readiness before operational pressure increases.
Author

International Expert in Ethics, Compliance, and Transparency
Thought Leader in Reporting on the Italian Sunshine Act
Edoardo, a former MedTech compliance manager, has over 25 years of experience in compliance and transparency. A recognized opinion leader, Edoardo has led ethics programs at major pharmaceutical companies and offers strategic insights into compliance practices in Italy.
Recent Blogs
Cerchi supporto per la compliance al Sunshine Act?
Hai domande pratiche?
Dai un’occhiata alla nostra sezione Domande Frequenti per risposte chiare su scadenze, obblighi e strategie.


